Dual Use Research is defined as projects that, based on current understanding, can be reasonably anticipated to provide knowledge, information, products, or technologies that could be directly misapplied to pose a significant threat with broad potential consequences to public health and safety, agricultural crops and other plants, animals, the environment, materiel, or national security. More specifically, the US Government Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern (“Policy for Institutional DURC Oversight”) defines DURC as involving one of the agents/toxins below AND is also used in one of the stated Experiments of Concern.
|Nonattenuated forms of:|
|Bacillus anthracis||Avian influenza virus (highly pathogenic)|
|Burkholderia mallei||Ebola virus|
|Burkholderia pseudomallei||Foot-and-mouth disease virus|
|Clostridium botulinum (toxin-producing strains)||Marburg virus|
|Francisella tularensis||Reconstructed 1918 influenza virus|
|Yersinia pestis||Rinderpest virus|
|Variola major and minor virus|
|Botulinum neurotoxin (any quantity)|
Experiments of Concern:
DURC is identified through the IBC registration form. If the IBC agrees that the research qualifies as DURC, it will be submitted to the DURC Committee to further review. This Committee will work with you to create a Risk Mitigation Plan that will be required by NIH, in addition, to any other USG agency that is providing the funding. It is important to note that this Plan will be required whether or not the project is funded by a USG agency.
Please review the Tufts University/Tufts Medical Center Policy on Dual Use Research of Concern for additional information.
Valerie Parkison, the IACUC/IBC Regulatory Director can be reached at (617) 636-5612 or by email at Valerie.firstname.lastname@example.org.
Melanie Marketon, the Biosafety Manager, can be reached by email at Melanie.email@example.com.